Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Composition 5-amino-1MQ: 50 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods (HPLC/LC-MS) for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
(December 2020)
The goal is to help improve energy stability, reduce fatigue, and support overall daily functioning
Clinical studies have confirmed that AOD-9604 shows no adverse effect on insulin sensitivity when assessed using glucose clamp techniques, unlike full-length growth hormone which can impair glucose metabolism
(AIs are established when there is insufficient information to determine EARs and RDAs.) For children ages 113 years, the RDA increases with age from 0.9 to 1.8 g/day
The magic of lipotropic B12 injections lies in their dual action
